Transcat (Transcat) Total Equity : $218.5 Mil (As of Dec. 2023)

View and export this data going back to 1990. Start your Free Trial

What is Transcat Total Equity?

Transcat's total equity for the quarter that ended in Dec. 2023 was $218.5 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Transcat Total Equity Historical Data

The historical data trend for Transcat's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transcat Total Equity Chart

Transcat Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Equity

Get a 7-Day Free Trial

59.63

67.09

75.08

86.18

99.63

Transcat Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Equity	Get a 7-Day Free Trial															95.28	99.63	110.72	138.25	218.47

Transcat Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Transcat's Total Equity for the fiscal year that ended in Mar. 2023 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2023 )	-	Total Liabilities(Q: Mar. 2023 )
	=	195.749	-	96.119
	=	99.6

Transcat's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	281.074	-	62.604
	=	218.5

Transcat Total Equity Related Terms

Thank you for viewing the detailed overview of Transcat's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Transcat (Transcat) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Distribution » Transcat Inc (NAS:TRNS) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

35 Vantage Point Drive, Rochester, NY, USA, 14624

Website

https://www.transcat.com

Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.

Executives

Lee D. Rudow	officer: Chief Operating Officer	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
James M. Jenkins	officer: Gen Counsel & VP of Corp Devt	1600 BAUSCH & LOMB PLACE, ROCHESTER NY 14604
Craig D. Cairns	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Dawn Deperrior	director	45 SOUTH MAIN STREET, FAIRPORT NY 14450
Christopher P. Gillette	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Charles P Hadeed	officer: VP-Finance and CFO	35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Scott Deverell	other: Principal Accounting Officer	100 CHESTNUT STREET, SUITE 600, ROCHESTER NY 14604
Richard J Harrison	director	44 SOUTHERN PARKWAY, ROCHESTER NY 14618
Theresa A. Conroy	officer: VP, Human Resources	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Cynthia Langston	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Thomas L Barbato	officer: Sr. VP Finance & CFO	105 NORTON STREET, NEWARK NY 14513
Carl E Sassano	director, officer: Chairman, President and CEO	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Gary J. Haseley	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Michael W. West	officer: VP Distribution & Marketing	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Mbago M. Kaniki	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624